What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Infectious Coryza in Poultry: Clinical Presentation, Diagnosis, and Management

Introduction

Infectious coryza is an acute respiratory disease of chickens, turkeys, and other gallinaceous birds caused by the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum). The disease is characterized by catarrhal inflammation of the upper respiratory tract, including the nasal passages, sinuses, and conjunctiva [1]. Infectious coryza results in significant economic losses in commercial poultry operations due to reduced egg production, increased mortality, and culling of affected birds [1, 2]. The condition is recognized globally, with notable prevalence in regions with intensive poultry production, including the United Kingdom, Asia, Africa, and the Americas [1, 2]. This article provides a detailed review of the etiology, epidemiology, clinical signs, pathology, diagnostic methods, treatment options, and control measures for infectious coryza, with specific attention to ocular manifestations and the disease status in the United Kingdom.

Etiology

The causative agent of infectious coryza is Avibacterium paragallinarum, a Gram-negative, nonmotile, pleomorphic rod belonging to the family Pasteurellaceae [1, 3]. The bacterium is fastidious, requiring nicotinamide adenine dinucleotide (NAD, V factor) for in vitro growth, and is typically cultured on chocolate agar or media supplemented with NAD [1, 3]. A. paragallinarum is classified into three serogroups (A, B, and C) based on the Page scheme, with further subdivision into serovars using hemagglutination inhibition assays [1, 4]. Serogroups A and C are the most commonly isolated from clinical cases, while serogroup B is less frequent but can cause severe disease [1, 4]. The bacterium produces a polysaccharide capsule that contributes to virulence by inhibiting phagocytosis [3]. Additionally, A. paragallinarum possesses hemagglutinin antigens that mediate attachment to host respiratory epithelial cells [3, 4]. The organism is fragile and survives poorly outside the host, being readily inactivated by desiccation, sunlight, and common disinfectants [1].

Epidemiology

Infectious coryza occurs worldwide and is endemic in many regions with high-density poultry production [1, 2]. Chickens of all ages are susceptible, but the disease is most commonly observed in growing pullets and adult layers [1, 2]. Turkeys, pheasants, guinea fowl, and quail can also be infected, although clinical signs may be less pronounced [1]. The primary mode of transmission is direct contact between infected and susceptible birds via respiratory droplets and aerosols [1, 2]. Indirect transmission through contaminated feed, water, equipment, and personnel is possible but less efficient due to the bacterium's poor environmental survival [1]. Carrier birds, including those with subclinical infections or those that have recovered, serve as important reservoirs for maintaining the pathogen within a flock [1, 2]. Stress factors such as overcrowding, poor ventilation, nutritional deficiencies, and concurrent infections (e.g., mycoplasmosis, colibacillosis) predispose birds to clinical disease [1, 2]. In the United Kingdom, infectious coryza is notifiable in some contexts, and outbreaks are reported periodically, particularly in multi-age layer flocks [1, 2]. The disease is more prevalent in temperate and subtropical climates, with seasonal peaks often associated with colder months when ventilation is reduced [1].

Clinical Presentation

The incubation period for infectious coryza ranges from 1 to 3 days following exposure [1, 3]. The disease typically has an acute onset, with clinical signs primarily referable to the upper respiratory tract. Affected birds exhibit serous to mucoid nasal discharge, which may become purulent and obstruct the nostrils [1, 3]. Sneezing, coughing, and rales are common [1]. Swelling of the infraorbital sinuses is a characteristic finding, often causing facial edema and periorbital swelling [1, 3]. Conjunctivitis with lacrimation and frothy ocular discharge is frequently observed [1, 3].

Infectious Coryza Eye

Ocular involvement in infectious coryza is a prominent feature, often described as "infectious coryza eye." The conjunctivitis can range from mild hyperemia to severe chemosis with accumulation of exudate [1, 3]. In some cases, the swelling of the periorbital tissues is so pronounced that it leads to partial or complete closure of the palpebral fissure [1]. Corneal ulceration and keratitis may occur secondary to mechanical irritation from exudate or concurrent infections [1]. The ocular discharge is initially serous but becomes mucopurulent as the disease progresses [1, 3]. Blindness is rare but can result from severe corneal damage [1]. The ocular signs are often bilateral but may be asymmetrical [1].

In addition to respiratory and ocular signs, affected birds may show depression, anorexia, and a drop in water consumption [1, 2]. In laying hens, egg production can decline by 10% to 40%, and egg quality may be compromised with thin shells and reduced internal quality [1, 2]. Mortality is generally low (1% to 5%) unless complicated by secondary bacterial infections such as Escherichia coli or Mycoplasma gallisepticum [1, 2]. In broilers, the disease can cause reduced weight gain and increased feed conversion ratio [1].

Pathology

Gross pathological findings in infectious coryza are confined to the upper respiratory tract. The nasal passages and infraorbital sinuses contain catarrhal to purulent exudate [1, 3]. The mucosa of the nasal turbinates and sinuses is hyperemic, edematous, and may be covered with a fibrinous pseudomembrane [1]. The conjunctiva is congested and thickened, with mucopurulent exudate in the conjunctival sac [1]. In severe cases, the trachea may contain frothy mucus, but the lower respiratory tract is typically unaffected unless secondary pathogens are present [1]. Histologically, there is acute catarrhal inflammation with infiltration of heterophils and mononuclear cells, desquamation of epithelial cells, and hyperplasia of mucous glands [1, 3]. The sinus epithelium may undergo squamous metaplasia in chronic cases [1].

Diagnosis

A presumptive diagnosis of infectious coryza is based on characteristic clinical signs, particularly nasal discharge, facial swelling, and conjunctivitis, along with flock history and epidemiological data [1, 2]. However, definitive diagnosis requires laboratory confirmation.

Sample Collection and Transport

Samples for bacterial isolation should be collected from acutely affected birds. Suitable specimens include nasal exudate, sinus swabs, or swabs from the infraorbital sinus collected aseptically [1, 3]. Swabs should be placed in transport medium (e.g., Amies with charcoal) and kept cool but not frozen during transport to the laboratory [1]. The bacterium is fragile, so prompt processing is essential [1].

Bacterial Isolation and Identification

Avibacterium paragallinarum is cultured on chocolate agar or blood agar with a nurse colony (e.g., Staphylococcus aureus) to provide NAD [1, 3]. Plates are incubated at 37 degrees Celsius in a 5% to 10% carbon dioxide atmosphere for 24 to 48 hours [1]. Colonies are small, dewdrop-like, and nonhemolytic [1]. Identification is based on Gram stain (Gram-negative pleomorphic rods), requirement for NAD (V factor), absence of hemolysis, and biochemical tests such as catalase (positive), oxidase (positive), and fermentation of glucose without gas production [1, 3]. Serotyping is performed using hemagglutination inhibition with specific antisera [1, 4].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the HMTp210 gene or the 16S rRNA gene are available for rapid and specific detection of A. paragallinarum [1, 3]. PCR can be performed directly on clinical samples (e.g., swabs) and is more sensitive than culture, especially when samples are degraded or when birds have received antibiotics [1, 3]. Real-time PCR assays allow quantification of bacterial load [1]. Molecular methods are particularly useful for confirming infectious coryza in the United Kingdom and other regions where rapid diagnosis is critical for outbreak management [1].

Serology

Serological tests, including the hemagglutination inhibition test and enzyme-linked immunosorbent assays (ELISAs), are available for detecting antibodies against A. paragallinarum [1, 4]. These tests are useful for flock-level surveillance and for confirming exposure, but they are not suitable for individual diagnosis due to the variable antibody response [1, 4]. Paired serum samples (acute and convalescent) can demonstrate seroconversion [1].

Differential Diagnosis

Several respiratory diseases of poultry present with similar clinical signs and must be differentiated from infectious coryza. Key differentials include:

Avian influenza (highly pathogenic and low pathogenic strains) and Newcastle disease can cause respiratory signs, facial swelling, and conjunctivitis, but they are typically associated with higher mortality and systemic signs [1, 2]. See Viral Diseases in Poultry: Epidemiology, Clinical Signs, and Differential Diagnosis.
Mycoplasma gallisepticum infection (chronic respiratory disease) produces similar upper respiratory signs but often has a more protracted course and may involve airsacculitis [1]. See Mycoplasma gallisepticum in Poultry: Chronic Respiratory Disease and Control Strategies.
Ornithobacterium rhinotracheale infection causes respiratory disease with sinusitis and conjunctivitis, but it is more common in turkeys and often involves pneumonia [1]. See Ornithobacterium rhinotracheale (ORT): A Comprehensive Guide to Respiratory Disease in Poultry.
Bordetella avium (turkey coryza) primarily affects turkeys and causes similar signs, but it is caused by a different bacterium [1]. See Bordetella avium Turkey Coryza (Rhinotracheitis) in Poultry.
Avian pneumovirus (turkey rhinotracheitis) and infectious laryngotracheitis virus can also produce respiratory signs, but they have distinct clinical and pathological features [1]. See Common Viral Diseases in Poultry: Diagnosis and Differential Considerations.
Fowl cholera (Pasteurella multocida) can cause facial edema and respiratory signs, but it is often associated with septicemia and high mortality [1]. See Fowl Cholera in Poultry: Pasteurella multocida Pathogenesis, Clinical Signs, Prevention, Control, and WOAH Classification.

A systematic diagnostic approach is essential. The following Mermaid diagram outlines a decision tree for diagnosing infectious coryza.

flowchart TD
    A[Clinical signs: nasal discharge, facial swelling, conjunctivitis], > B{Collect samples from acute cases}
    B, > C[Nasal/sinus swabs in transport medium]
    C, > D[Laboratory processing]
    D, > E{Culture on chocolate agar + NAD}
    E, > F[Colonies: small, dewdrop-like, Gram-negative rods]
    F, > G[Biochemical identification: NAD requirement, catalase +, oxidase +]
    G, > H[Serotyping by HI]
    D, > I[PCR on clinical samples]
    I, > J[Positive for A. paragallinarum]
    H, > K[Confirm diagnosis]
    J, > K
    K, > L[Consider differentials: AI, ND, MG, ORT, fowl cholera]
    L, > M[Implement treatment and control measures]

Treatment

Antimicrobial therapy is the mainstay of treatment for infectious coryza, but it must be initiated early to be effective [1, 2]. The bacterium is susceptible to several antibiotics, including sulfonamides, tetracyclines, tylosin, erythromycin, and fluoroquinolones [1, 2]. However, antimicrobial resistance has been reported, particularly to sulfonamides and tetracyclines, so susceptibility testing is recommended [1, 2]. Treatment is typically administered via drinking water for 3 to 5 days [1]. In severe outbreaks, individual bird injection with long-acting oxytetracycline or tylosin may be used [1]. Supportive care, including improving ventilation, reducing stocking density, and providing clean water and feed, is important to aid recovery [1, 2]. Treated birds often show clinical improvement within 24 to 48 hours, but relapses can occur if treatment is discontinued prematurely or if carrier birds remain [1]. For detailed treatment protocols, see Infectious Coryza in Chickens: Drugs, Treatment Protocols, and Differential Diagnosis.

Control and Prevention

Control of infectious coryza relies on a combination of biosecurity, management practices, and vaccination [1, 2].

Biosecurity

Strict biosecurity measures are essential to prevent introduction and spread of A. paragallinarum. These include all-in-all-out production, cleaning and disinfection of facilities between flocks, controlling visitor access, and using dedicated equipment for each house [1, 2]. Rodent and wild bird control should be maintained, as they can mechanically transmit the bacterium [1]. Quarantine of new birds and isolation of sick birds are critical [1].

Vaccination

Vaccines are available for infectious coryza and are commonly used in layer flocks in endemic areas [1, 4]. Commercial vaccines are typically inactivated bacterins containing multiple serogroups (A, B, and C) to provide broad protection [1, 4]. Vaccination is administered subcutaneously or intramuscularly, usually at 8 to 12 weeks of age, with a booster before the onset of lay [1, 4]. Vaccine efficacy varies depending on the match between vaccine serovars and field strains [1, 4]. Autogenous vaccines can be prepared from local isolates [1]. Vaccination reduces clinical signs and egg production losses but does not prevent infection or carriage [1, 4].

Eradication

Eradication of infectious coryza from a flock is difficult due to the carrier state. Depopulation of infected flocks followed by thorough cleaning and disinfection and a downtime period of at least 2 weeks is the most effective method [1, 2]. In multi-age sites, eradication may require depopulation of the entire facility [1]. In the United Kingdom, eradication programs may be implemented in coordination with veterinary authorities [1].

Conclusion

Infectious coryza remains a significant respiratory disease of poultry worldwide, causing substantial economic losses. The disease is characterized by nasal discharge, facial swelling, and conjunctivitis, with ocular involvement being a hallmark feature. Diagnosis requires laboratory confirmation through bacterial isolation, PCR, or serology. Treatment with appropriate antimicrobials can reduce clinical signs, but control relies on biosecurity, vaccination, and, where feasible, eradication. Understanding the epidemiology and clinical presentation of infectious coryza is essential for effective management in both commercial and backyard flocks.

References

[1] Blackall PJ, Soriano-Vargas E. Infectious coryza. In: Swayne DE, Boulianne M, Logue CM, et al., editors. Diseases of Poultry. 14th ed. Hoboken, NJ: Wiley-Blackwell; 2020. p. 890-906.

[2] Merck Veterinary Manual. Infectious coryza in poultry. Kenilworth, NJ: Merck & Co., Inc.; 2023. Available from: https://www.merckvetmanual.com/poultry/infectious-coryza.

[3] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.11: Infectious coryza. Paris: WOAH; 2023.

[4] Jacobs AAC, van den Berg J. Vaccination against infectious coryza. In: Pattison M, McMullin PF, Bradbury JM, Alexander DJ, editors. Poultry Diseases. 6th ed. Edinburgh: Saunders Elsevier; 2008. p. 210-218. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.